国际皮肤性病学杂志    2004 30 (4): 238-240   ISSN: 2096-5540  CN: 32-1880/R   抗核小体抗体在系统性红斑狼疮中的意义 袁玲玲, 卢宪梅, 赵天恩 山东省皮肤病医院, 济南250022 收稿日期 2003-11-07  修回日期 null  网络版发布日期 null 参考文献  [1] Enlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol,1994, 152:3685-3692. [2] Rekvig OP, Moens U, Sundsfjord A, et al. Experimental expression in mice and spontaneous expression in human SLE of polyomavirus Tantigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Invest, 1997, 99:2045-2054. [3] Bruns A, Blass S, Hausdorf G, et al. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum,2000, 43:2307-2315. [4] Chabre H, Amoura Z, Piette JC, et al. Presence of nucleosome-re-strieted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum, 1995, 38:1485-1491. [5] Burlingame RW, Rubin RL. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods, 1990,134:187-199. [6] Franek F, Dolnikova J. Nucleosomes occurring in protein-free hybridoma cell culture. Evidence for programmed cell death. FEBS Lett,1991,284:285-287. [7] Kramers C, Hylkema MN, van Bruggen MC, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest, 1994, 94:568-577. [8] Grootscholten C, van Bruggen MC, van der Pijl JW, et al. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum, 2003,48:1355-1362. [9] Amoura Z, Koutouzov S, Chabre H, et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases:antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum,2000, 43:76-84. [10] Cairns AP, McMillan SA, Crockard AD, et al. Antinucleosome antibodies in the diagnosis of systemic lupus erythematosus. Ann Rheum Dis, 2003, 62:272-273. [11] Simon JA, Cabiedes J, Ortiz E, et al. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology (Oxford), 2004, 43:220-224. [12] Min DJ, Kim SJ, Park SH, et al. Anti-nucleosome antibody:significance in lupus patients lacking anti-double-stranded DNA antibody.Clin Exp Rheumatol, 2002, 20:13-18. [13] Horak P, Scudla V, Hermanovo Z, et al. Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus.Clin Rheumatol, 2001,20:337-344. [14] Kiss E, Lakos G, Nemeth J, et al. Significance of anti-nucleosome (anti-chromatin) auto-antibodies in systemic lupus erythematosus.Orv Hetil, 2001, 142:1731-1736. [15] Benucci M, Gobbi FL, Del Rosso A,et al. Disease activity and antinucleosome antibodies in systemic lupus erythematosus. Scand J Rheumatol, 2003, 32:42-45. [16] Kaliyaperumal A, Michaels MA, Datta SK. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides:tolerance spreading impairs pathogenic function of autoimmune T and B cells. J Immunol, 1999, 162(10):5775-5783. 通讯作者: